Top 3 Tech M&As of 2017: Identifying Threats & Opportunities Using IP Data

Posted by Timi Olotu on July 28, 2017 at 4:11 PM

Every M&A deal happens because a company wants something and it thinks that acquiring another company (or type of company) will lead to the desired outcome. This article will explain how the acquiring company can use intellectual property (IP) data to:

Read More

Topics: IP & Innovation, IP Risk, Corporate Strategy, IP Analysis, M&A, Innovation, Mergers, Acquisitions

A holistic view of intellectual property and how to use it strategically

Posted by Hejab Azam on July 19, 2017 at 5:14 PM

I had the pleasure of interviewing Liz Ward, Principle of Virtuoso Legal, a boutique IP firm. If there’s any law firm that understands the holistic view and strategic use of intellectual property, it’s them. Although Virtuoso is a small boutique IP firm, they have outcompeted large magic circle firms by wining second place for ‘IP team of the year’ at The Lawyer Magazine Awards 2017.

Read More

Topics: IP & Innovation, IP Risk, Intellectual Property, IP Analysis

PatSnap Platform Upgrade: Smarter Decisions with Extended Families & Standard-Essential Patents

Posted by Timi Olotu on July 10, 2017 at 2:28 PM

Read More

Topics: IP & Innovation, IP Risk, R&D, IP Analysis, PatSnap Platform, Innovation

Businesses that own no patents use patent data to increase revenue, so why don’t you?

Posted by Hejab Azam on July 6, 2017 at 11:49 AM
Read More

Topics: IP & Innovation, IP Risk, R&D, IP Analysis, Innovation

Patent valuation - Indicator approach

Posted by Hejab Azam on March 17, 2017 at 12:00 PM

 

Read More

Topics: IP Analysis

Patent valuation: Income approach

Posted by Hejab Azam on March 15, 2017 at 11:31 AM

What is the income approach to patent valuation?

Read More

Topics: IP Analysis

Patent valuation methodologies: Market value approach

Posted by Hejab Azam on March 13, 2017 at 9:43 AM

What is the market value approach for patent valuation?

The market value approach attempts to assign a value of an asset on the open market based on information from similar market transactions.

Read More

Topics: IP Analysis

Patent valuation methodologies: The cost based approach

Posted by Hejab Azam on March 9, 2017 at 3:21 PM

Why is patent value important?

Monetising IP and patents is important for any company that wants to buy or sell their portfolio yet many companies struggle to value their patent portfolio because it is an intangible asset which can and will change over time. With certain IP, such as trademarks, the value can actually increase over time as the brand grows in stature.

Read More

Topics: IP Analysis

Webinar Review: IP portfolio management for SMEs

Posted by Hejab Azam on February 1, 2017 at 10:00 AM

This webinar was hosted by guest speaker Timothy Butler, CEO of asset intelligence firm Tego. In this webinar, he discusses techniques for IP portfolio management for small medium enterprises (SMEs). With plenty of examples from Tego, he explains how to develop a strong IP portfolio in such competitive markets.

Read More

Topics: startups, IP Analysis

Webinar Review: Laura Schoppe talks IP opportunities

Posted by Joe Bamsey on January 13, 2017 at 2:30 PM

In our latest webinar Laura Schoppe, founder of Fuentek, gave us her insights into how IP data can be used to identify commercialization opportunities. Following Laura’s presentation there was a Q&A session where viewers were given the opportunity to ask Laura any questions they had on the topic.

Read More

Topics: PatSnap Webinar, IP Analysis

The most informative articles across R&D and IP—all in one newsletter

Academy by PatSnap—free video courses for R&D and IP innovators 

Join PatSnap's free Academy to learn how you can increase innovation ROI and foster a productive culture—from ideation to commercialisation.

Learn for Free

Pharmaceuticals guide on turning expiring patents into priceless opportunities

Do you know which patents in your specialist sector are due to expire? Do you know how they can help you outthink competitors? Reading this eBook ensures you do.

 

Download Now

How to solve declining R&D productivity and ROI—10 experts provide answers

Former president of R&D at Pfizer and 9 cross-industry experts diagnose the top R&D challenges—and how you can solve them.

Read Expert Guide

Get a full test run on the PatSnap platform—no cost, no strings

Wondering exactly how PatSnap would fit into and benefit your business? Request a demonstration, tailored to address your needs, from one of our tech experts.

REQUEST A DEMO